Miranda Bailey | Health Economics and Outcome Research & Pricing
Rocket Pharmaceuticals, Inc.
Miranda Bailey is the Associate Vice President of HEOR & Pricing at Rocket Pharmaceuticals, with over 15 years of experience driving value, access, and health outcomes in rare diseases and gene therapies. She has created and implemented successful global and local market access, HEOR and RWE strategies for a number of innovative key launch assets at Novartis Gene Therapies, Novartis, GSK and within consultancy, combining strategic market access expertise with deep HEOR knowledge and innovation.
Appearances:
Day 1 - Tuesday 28 October @ 15:20
Solving the Rare Disease Puzzle Through Thought Partnership
This 15-minute session explores the value of true thought partnership between industry and consultancy in navigating the complex HEOR and market access landscape for rare disease assets. We will define what thought partnership really means, highlight the unique evidence and access challenges in rare diseases, and show how collaborative, strategic engagement can overcome these barriers to deliver meaningful impact for patients and stakeholders.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events